CLINICAL STUDIES ON TMS-19-Q·GC TABLET IN DERMATOLOGICAL SUPERFICIAL INFECTION

DOI

Bibliographic Information

Other Title
  • 表在性皮膚感染症に対するTMS-19-Q・GC錠の臨床的検討

Abstract

TMS-19-Q·GC tablet, a new developed macrolide antibiotic, was administered to 21 patients, 7 with folliculitis, 7 with furuncle, 3 with infectious atheroma and 4 with subcutaneous abscess at daily dose of 300mg or 400mg for 7-33 days.<BR>The results were summarized as follows: Cured in 15 cases, markedly improved in 3 cases, moderately improved in 3 cases.<BR>Effectiveness rate was 100% and neither side effect nor abnormal laboratory finding was observed in any case.

Journal

  • CHEMOTHERAPY

    CHEMOTHERAPY 32 (Supplement6), 505-509, 1984

    Japanese Society of Chemotherapy

Details 詳細情報について

Report a problem

Back to top